Aditya Birla Sun Life Mutual FundOther Scheme - Index Funds5.1 years
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Sept 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Prefer peers if · Prefer Axis CRISIL IBX 50:50 Gilt Plus SDL June 2028 Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
5.1 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.21% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -3.3%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 100.0% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 3%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
5 Apr 2022 – 11 Nov 2022
Trough 7 Jun 2022 · recovered in 157 days
-3.3%
17 Dec 2021 – 10 Feb 2022
Trough 3 Feb 2022 · recovered in 7 days
-0.9%
28 Feb 2022 – 25 Mar 2022
Trough 11 Mar 2022 · recovered in 14 days
-0.4%
1 Oct 2021 – 8 Nov 2021
Trough 8 Oct 2021 · recovered in 31 days
-0.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
30
Vs category
100
Consistency
18
Risk-adjusted
28
Drawdown
92
Mean
54
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
30 Sept 2026 · 3 holdings · top 10 are 100.0%.
Repo
Unspecified
50.9%
Reverse Repo
Unspecified
45.1%
Net Receivables
Unspecified
4.0%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
8 Sept 2026
DECISION
Status moved from HEALTHY to MONITOR.
8 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Mutual Fund
DSP Mutual Fund
Nippon India Mutual Fund
Edelweiss Mutual Fund
Caveat: Lower trailing returns
Kotak Mahindra Mutual Fund
Caveat: Lower trailing returns
Aditya Birla Sun Life Mutual FundOther Scheme - Index Funds5.1 years
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Sept 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Prefer peers if · Prefer Axis CRISIL IBX 50:50 Gilt Plus SDL June 2028 Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
5.1 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.21% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -3.3%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 100.0% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 3%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
30 Sept 2026 · +5.9% over 1Y
13.3594
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Sept 2026
0.0%
5 Apr 2022 – 11 Nov 2022
Trough 7 Jun 2022 · recovered in 157 days
-3.3%
17 Dec 2021 – 10 Feb 2022
Trough 3 Feb 2022 · recovered in 7 days
-0.9%
28 Feb 2022 – 25 Mar 2022
Trough 11 Mar 2022 · recovered in 14 days
-0.4%
1 Oct 2021 – 8 Nov 2021
Trough 8 Oct 2021 · recovered in 31 days
-0.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
30
Vs category
100
Consistency
18
Risk-adjusted
28
Drawdown
92
Mean
54
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
30 Sept 2026 · 3 holdings · top 10 are 100.0%.
Repo
Unspecified
50.9%
Reverse Repo
Unspecified
45.1%
Net Receivables
Unspecified
4.0%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
8 Sept 2026
DECISION
Status moved from HEALTHY to MONITOR.
8 Sept 2026